Content about Ferring Pharmaceuticals

March 19, 2014

Ferring Pharmaceuticals announced that it received approval from the Food and Drug Administration for new labeling of its fertility products Menopur and Bravelle.

PARSIPPANY, N.J. — Ferring Pharmaceuticals announced that it received approval from the Food and Drug Administration for new labeling of its fertility products Menopur and Bravelle. The update is a result of the Combine trial, which showed that both Menopur and Bravelle can be safely mixed and administered in a single injection.

January 7, 2013

Drug maker Prasco Labs has launched an authorized generic version of a drug used to treat heavy menstrual bleeding, the company said.

CINCINNATI, Ohio — Drug maker Prasco Labs has launched an authorized generic version of a drug used to treat heavy menstrual bleeding, the company said Monday.

Prasco announced the launch of tranexamic acid tablets in the 650 mg strength, an authorized generic version of Ferring Pharmaceuticals' Lysteda. Authorized generics are branded drugs marketed under their generic names at a discount, usually through third-party companies, to compete with Food and Drug Administration-approved generics.

January 3, 2013

The Food and Drug Administration has approved a generic drug for heavy menstrual bleeding made by Watson Pharmaceuticals, the drug maker said.

PARSIPPANY, N.J. — The Food and Drug Administration has approved a generic drug for heavy menstrual bleeding made by Watson Pharmaceuticals, the drug maker said Thursday.

Watson announced the approval of tranexamic acid tablets through a subsidiary and plans to ship it immediately. The drug is a generic version of Ferring Pharmaceuticals' Lysteda.

Ferring has filed suit against Watson, alleging that the generic drug infringes two of its patents. Lysteda had sales of about $25 million during the 12-month period that ended in November, according to IMS Health.

September 6, 2012

Walgreens will offer products and other resources for women who have fertility complications due to cancer treatment, under a partnership with Ferring Pharmaceuticals announced Thursday.

PARSIPPANY, N.J. — Walgreens will offer products and other resources for women who have fertility complications due to cancer treatment, under a partnership with Ferring Pharmaceuticals announced Thursday.

June 20, 2010

Drug maker Ferring Pharmaceuticals has launched a new treatment for women with cyclic heavy menstrual...

May 9, 2010

Ferring Pharmaceuticals has bought global rights to a women’s health drug made by U.S. drug...